Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements

This episode is the first of our new 2024 series – Preparing for a Cell and Gene Future. In this episode, we take a look back at a banner year for cell and gene therapies and what to expect in 2024 in terms of next-generation therapies and gene editing progress with Chris Learn, Senior Vice President and Head of the Cell and Gene Center of Excellence.


Return to Insights Center

Related Insights


Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024


The New Frontier of Innovative Therapies: Navigating What's Next

Jan 12, 2023


Three ways to improve your chances that insurers will pay for a new CGT

Feb 18, 2021


Regulatory, clinical and logistics challenges of ATMPs in clinical research

Apr 22, 2021


Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021


Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Apr 4, 2022


Cell & Gene Therapies: A Regulatory Update

Jul 22, 2022


SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Aug 24, 2022


Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit

Sep 19, 2022


Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023


Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024


New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023